about us

Aurélien Baudot holds a double MSc in Bioscience Engineering and Artificial Intelligence. Over the past decade, he has built broad expertise across the biotech sector, specialising in molecular biology, lab automation, advanced analytics, and gut microbiome research. As CEO of Cryptobiotix, he leads the company’s strategic direction and commercial growth, working closely with clients to understand their scientific questions and shape the solutions of tomorrow.

Dr. Pieter Van den Abbeele is an expert in gut microbiome research and co-inventor of Cryptobiotix’s proprietary SIFR^® technology  pipeline. As CSO, he drives the scientific vision and innovation pipeline, ensuring the company’s solutions remain at the forefront of preclinical gastrointestinal simulation. His work bridges the gap between preclinical and clinical research, helping global partners in food, feed, biotech, and pharma to accelerate product development while reducing the reliance on animal testing.

Dr. Lien Van den Bossche oversees all operations at Cryptobiotix, ensuring excellence, quality control, and compliance with regulatory standards. With a background in biotechnology and extensive hands-on experience in microbiome research, she manages the day-to-day execution of projects, the planning of resources, and drives the continuous optimisation of lab workflows. Her leadership ensures that client studies are delivered on time, with the highest scientific and technical standards.